Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$122.97 - $147.0 $353,538 - $422,625
-2,875 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$121.19 - $165.49 $348,421 - $475,783
2,875 New
2,875 $419,000
Q3 2019

Nov 08, 2019

SELL
$70.9 - $87.82 $126,840 - $157,109
-1,789 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$65.86 - $92.79 $117,823 - $166,001
1,789 New
1,789 $130,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.